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Abstract
Background: In bovine maturing oocytes and cleavage stage embryos, gene expression is mostly controlled at the post-
transcriptional level, through degradation and deadenylation/polyadenylation. We have investigated how post transcriptional
control of maternal transcripts was affected during in vitro and in vivo maturation, as a model of differential developmental
competence.
Results: Using real time PCR, we have analyzed variation of maternal transcripts, in terms of abundance and polyadenylation,
during in vitro or in vivo oocyte maturation and in vitro embryo development. Four genes are characterized here for the first
time in bovine: ring finger protein 18 (RNF18) and breast cancer anti-estrogen resistance 4 (BCAR4), whose oocyte preferential
expression was not previously reported in any species, as well as Maternal embryonic leucine zipper kinase (MELK) and STELLA.
We included three known oocyte marker genes (Maternal antigen that embryos require (MATER), Zygote arrest 1 (ZAR1),
NACHT, leucine rich repeat and PYD containing 9 (NALP9)). In addition, we selected transcripts previously identified as
differentially regulated during maturation, peroxiredoxin 1 and 2 (PRDX1, PRDX2), inhibitor of DNA binding 2 and 3 (ID2, ID3),
cyclin B1 (CCNB1), cell division cycle 2 (CDC2), as wel l as Aurora A (AURKA). Most transcripts underwent a moderate
degradation during maturation. But they displayed sharply contrasted deadenylation patterns that account for variations
observed previously by DNA array and correlated with the presence of a putative cytoplasmic polyadenylation element in their
3' untranslated region. Similar variations in abundance and polyadenylation status were observed during in vitro maturation or
in vivo maturation, except for PRDX1, that appears as a marker of in vivo maturation. Throughout in vitro development, oocyte
restricted transcripts were progressively degraded until the morula stage, except for MELK ; and the corresponding genes
remained silent after major embryonic genome activation.
Conclusion: Altogether, our data emphasize the extent of post-transcriptional regulation during oocyte maturation. They do
not evidence a general alteration of this phenomenon after in vitro maturation as compared to in vivo maturation, but indicate
that some individual messenger RNA can be affected.
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Background
The fully grown oocyte (FGO) ability to sustain genome
reprogramming and embryo development is associated
with a specific and complex pattern of gene expression.
This has prompted high-throughput studies of the mam-
malian oocyte transcriptome in mouse [1,2], in human
[3] or bovine [4]. In most tissues, the transcriptome
reflects the contemporary pattern of RNA synthesis and
protein synthesis. In this respect, the fully grown and
maturing oocytes are atypical models, since at these stages
the oocyte is essentially transcriptionally quiescent.
Rather, the FGO transcriptome results from active RNA
synthesis during the oocyte growth phase, followed by
post-transcriptional regulation. A subset of maternal tran-
scripts undergoes post-transcriptional regulation through
shortening of the polyA tail, and is stored protected from
degradation and from the translation machinery. At the
time when the protein is required, during maturation, fer-
tilization or the early stages of embryo development, such
dormant transcripts can undergo cytoplasmic polyade-
nylation and support translation, then are rapidly
degraded. The underlying molecular mechanisms were
shown to involve cis  regulatory elements within the 3'
untranslated region, including cytoplasmic polyadenyla-
tion elements (CPE) (for reviews, see [5-7]). However,
during maturation most maternal transcripts are expected
to follow a default deadenylation and degradation path-
ways [8-10].
Besides a complex post-transcriptional regulation path-
way, the mammalian oocyte transcriptome is character-
ized by specific transcripts not found in somatic tissues, as
first evidenced in mouse [11-13]. The hypothesis that so-
called oocyte-specific genes would be important for fertil-
ity was confirmed by functional genomics experiments in
mouse (reviewed in [12]). A first class of genes is required
for normal folliculogenesis and fertilization. Other genes
are maternal effect genes, i.e. they are dispensable until
fertilization but they are required for proper embryo
development: most embryos from mothers null for
Zygote arrest 1 (Zar1), Maternal antigen that embryos
require (Mater, official symbol Nalp5 as a member of the
NACHT, leucine rich repeat and PYD containing, (NALP)
family), or Stella (official name Developmental pluripo-
tency associated 3 (Dppa3)) are blocked before the blasto-
cyst stage [14-17]. Functional importance of other oocyte-
enriched genes remains to be assessed, such as Oocyte
secreted protein 1 (Oosp1), Maternal embryonic leucine
zipper kinase (Melk), the Oogenesin genes and several
Nalp family members [13,18-21] (Studies in bovine have
identified orthologous genes, as well as potentially novel
oocyte-specific genes in this species [22-27].
The main objective of this study was to investigate post-
transcriptional regulation of maternal transcripts during
bovine oocyte maturation in relation with its quality, i.e.
its ability to undergo meiosis and sustain embryo devel-
opment. Bovine is definitely a pertinent scientific model
to analyze the relationship between oocyte developmen-
tal competence and the regulation of maternal transcripts.
First, embryonic genome major activation is delayed up to
the 8/16 cell stage about 3.5 days after fertilization,
whereas in mouse it is already completed 24 hrs after fer-
tilization at the end of the 2-cell stage. This chronology
highlights the importance of timely control of maternal
RNA. Most importantly, several physiological and experi-
mental models of oocyte quality have been defined in this
species (reviewed in [28]). In particular, in vivo matured
oocytes present the highest developmental competence
(as estimated by the blastocyst rate), while in vitro matu-
ration remains a suboptimal alternative [29-32]. As
nuclear maturation is not affected, the difference is usu-
ally attributed to an inadequate reproduction of the cyto-
plasmic features of oocyte maturation in vitro.
Here, using real time PCR, we have analyzed the variation
of maternal transcripts during bovine oocyte maturation
and embryo development, in terms of abundance and
polyadenylation. We selected genes likely involved in
oocyte quality, based on their restricted expression in the
germ cell or their previous isolation as markers of matura-
tion [33]. Three oocyte specific genes (MATER, NALP9
and  ZAR1) were previously identified. Four additional
genes are characterized here for the first time: the bovine
MELK  and  STELLA  genes, as well as two genes whose
oocyte preferential expression was not previously
reported in any species, ring finger protein 18 (RNF18)
and breast cancer anti-estrogen resistance 4 (BCAR4). We
also examined the cell-cycle regulator Aurora A (AURKA)
whose transcript is abundant in meiotically arrested
oocytes. In addition, we followed 6 transcripts previously
identified as down- or up-regulated during oocyte matura-
tion: cyclinB1 (CCNB1) and cell division cycle 2 (CDC2)
encoding components of the M-phase promoting factor,
as well as peroxiredoxin (PRDX) 1 and 2, and inhibitor of
DNA binding (ID) 2 and 3 [33]. Overall, our results show
a moderate degradation of most transcripts during matu-
ration, and evidence contrasted deadenylation patterns
that mostly account for variations observed previously by
DNA array. As a differential model of developmental
competence, we compared regulation of maternal tran-
scripts during in vitro and in vivo maturation. During
embryonic development, distinct profiles were observed,
and most oocyte marker genes remained silent after
embryonic genome activation.BMC Developmental Biology 2007, 7:125 http://www.biomedcentral.com/1471-213X/7/125
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Results
Characterization of four bovine genes preferentially 
expressed in the oocyte
We characterized transcripts represented by five distinct
EST in our library of EST preferentially represented in
bovine oocyte as compared to somatic tissues [23]. One
EST presented a high sequence homology with the human
MELK gene, while four others did not return a match. Vir-
tual Northern blots were run and hybridized using the
considered EST as probes. Then, full length transcript
sequence was determined by Rapid Amplification of
cDNA Ends (RACE). Gene structure and chromosomal
localization was deduced by aligning the full length cDNA
and the bovine genome sequences. We were able to iden-
tify the three remaining genes as STELLA,  RNF18  and
BCAR4.
MELK
One EST was 88% homologous to human MELK. As
observed by RT-PCR, MELK is not really oocyte specific;
rather, it is expressed at low level in most tissues, but
strongly expressed in both the male and female gonads
and in the oocyte (Fig 1A). A virtual Northern blot
revealed a single 2.5 kbp cDNA (not shown). The full
length 2445 bp sequence deduced from RACE (genbank
accession hoEF446902) is assembled from 18 exons,
including a first non coding exon that is lacking in the
bovine  MELK  transcript that has since been predicted
within the genome onto BTA8. The full-length sequence
contains a 1953 nucleotide long open reading frame
(ORF), encoding a predicted 650 aa/74 kD protein wse
sequence is 90% and 80% identical to its human and
mouse counterparts, respectively; it presents similar ser-
ine/threonine kinase domain and kinase associated
domain at the N-terminus and C-terminus respectively.
STELLA
Two independent EST initially could not be identified
based on their sequence, including previously described
EST5B4 [23]. By virtual Northern blot we observed a dou-
blet: the corresponding 1590 and 1347 bp long cDNA, as
deduced from RACE, are generated by alternative splicing
at their 5' end (Fig 1B) (genbank accession EF446904,
EF446905). They present the same 492 nt ORF encoding
a 163 aa putative protein. We identified a bovine ortho-
logue of the germ cell marker Stella, despite limited
sequence homology with the human and mouse counter-
parts (30% and 26% respectively). By RT-PCR, both vari-
ants were undetected in somatic tissues. Variant 1 was
detected in testis, ovary and oocyte, while variant 2 was
detected only in oocytes (Fig 1A).
RNF18
Initially our EST could not be identified by sequence
homology with sequences in public databases. By RT-
PCR, the transcript was specifically detected in testis,
ovary and oocyte (Fig. 1A). A 1723 bp cDNA, observed by
virtual Northern blot, was cloned by RACE (genbank
accession EF446903). The 1353 nt long ORF encodes a
450 aa/52 kD putative protein with 3 major regions: a N-
terminal ring finger, a B-box, and a C-terminal SPRY
domain also found in ryanodine receptor. This structure
identifies the protein as a member of the tripartite motif
(TRIM) family. The corresponding locus LOC525113 on
BTA29 has since been predicted from the bovine genome
with the annotation "similar to ring finger protein 18
(Testis-specific ring-finger protein)", whose human ortho-
logue was found primarily expressed in testis [34] and is
also named TRIM49. Identity is confirmed by analogous
gene structure, with six coding exons of similar length in
human and bovine. As compared to the predicted bovine
transcript, our cDNA contains three additional exons,
Characterization of oocyte specific transcripts Figure 1
Characterization of oocyte specific transcripts. (A) 
Expression pattern of MELK, RNF18, BCAR4 and STELLA in 
bovine somatic and gonadic tissues by RT-PCR. Tissues are 
indicated above the lanes: brain (Br), heart (He), pituitary 
gland (Pt), intestine (In), liver (Li), lung (Lu), muscle (Mu), 
spleen (Sp), uterus (Ut), testis (Te), Ovary (Ov), oocyte 
(Oo); no PCR substrate as negative control (-). RT-PCR for 
ACTB is shown as a positive control. An estimated 500-fold 
higher amount of substrate was used in PCR for somatic tis-
sues and gonads as compared to the oocyte. (B) Schematic 
representation of STELLA transcript variants generated by 
alternative splicing. (C) Schematic representation of BCAR4 
variants generated by alternative use of two polyadenylation 
signals (AAUAAA).
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including a 5' non coding exon and two short coding
exons.
BCAR4
Two transcripts (genbank accession EF446906,
EF446907) observed by virtual Northern blot were cloned
by RACE starting from our unidentifiable EST. They are
638 and 1317 bp long respectively, and are generated
through the alternative use of two polyadenylation sig-
nals, downstream a putative cytoplasmic polyadenylation
element (Fig. 1C). The 363 nt long ORF encodes a puta-
tive 120 aa/14 kD protein. The bovine gene is located
onto BTA25, between two loci annotated "similar to zinc
finger CCCH-type domain containing 7" and "ribosomal
L1 domain containing 1"respectively. By conserved syn-
teny we identified the human ortholog breast cancer anti-
estrogen resistance 4 (BCAR4). Both the bovine and
human ORF are included within a single exon, and
encode proteins with two putative transmembrane
domains; yet they do not display significant sequence
identity. In human, ESTs have been isolated mainly from
placenta, and to our knowledge expression of BCAR4 has
not been reported in the gonads or the oocyte. By RT-PCR
the transcript was detected specifically in the ovary at trace
level and in the oocyte (Fig. 1A).
Variation of maternal transcripts during in vitro 
maturation
We followed the variation of selected maternal transcripts
during in vitro oocyte maturation, in terms of abundance
and polyadenylation. Real-time PCR was run onto ran-
dom hexamer-primed RT products, in order to estimate
their abundance, and oligo(dT)15-primed RT products,
which are affected by both abundance and polyadenyla-
tion. For each transcript, the ratio to the mean value in
immature oocytes is represented (Fig 2). For most tran-
scripts, including 18S ribosomal RNA, the abundance did
not vary significant during maturation, although an aver-
age 20% decrease was observed. PRDX1, ID2 and MATER
transcripts appeared the most affected (over 33%
degraded). As expected due to transcription repression
during maturation, no transcript displayed a significant
increase. The patterns of polyadenylated transcripts
revealed sharp contrasts. CDC2,  PRDX1,  PRDX2,  ID2,
MATER, ZAR1 transcripts were strongly affected, as detec-
tion level dropped below one third of their initial level.
For all these genes, variations of the total and polyade-
nylated forms were significantly different during matura-
tion (Fig. 2, *). For NALP9  and  BCAR4  variant 1, the
decrease (41 and 49% respectively) was still more impor-
tant than the decline observed for the total form (27 and
23%), but the difference was not statistically significant.
On the other hand, seven genes appeared hardly affected;
the polyadenylated transcript followed a parallel evolu-
tion as the total form, and decreased by less than 30%.
These were AURKA, CCNB1, ID3, MELK, RNF18, STELLA
(two variants analyzed individually), and BCAR4 (both
variants analyzed together).
Comparison of in vitro maturation and in vivo maturation
In order to compare the variation of maternal transcripts
during in vitro and in vivo maturation, a subset of genes
was followed in oocytes collected by ovum pick up (OPU)
(Fig. 2). BCAR4 variant 1, STELLA variant 2, ID2 and ID3
transcripts were not quantified in these minute samples
due to requiring more substrate. Again, for most tran-
scripts the total form displayed a limited and statistically
non significant variation during maturation. An exception
was PRDX1, whose detection level dropped by 62% dur-
ing in vivo maturation: this was statistically different from
both the level in immature oocytes and the 33% drop dur-
ing in vitro maturation (Fig. 2, ≠). As observed during in
vitro maturation, polyadenylated transcripts displayed
more contrasted patterns. ACTB, PRDX1, PRDX2, CDC2,
MATER, NALP9, ZAR1 decreased significantly (Fig. 2, *).
Indeed, for polyadenylated transcripts, the mean values
were often remarkably close after in vitro and in vivo mat-
uration. Interestingly, PRDX1  polyadenylated form dis-
played a similar variation in both cases.
Profile of maternal transcripts during preimplantation 
development
Then we analyzed the variation of oocyte markers during
the early stages of embryo development (Fig. 3). As exam-
ples of housekeeping genes, we quantified 18S and ACTB
transcripts. Their levels started to increase between the 5/
8-cell and morula stages, as expected since major genome
activation occurs in bovine at the 8/16-cell stage, and rose
further during blastocyst formation and hatching. By con-
trast, detection of all oocyte markers decreased between
the 5/8-cell and morula stages, and all but MELK
decreased further in blastocysts, often below detection
level. MELK was indeed activated in blastocysts.
By the zygote stage, most transcripts (18S, ACTB, MATER,
NALP9, ZAR1, BCAR4) had fallen below half their level in
immature oocytes. Four transcripts remained fairly abun-
dant in 2-cell embryos, i.e. over 60% of their initial level:
MELK, RNF18, STELLA variant 1 and AURKA, whose level
decreased progressively throughout pre-MET develop-
ment.
Finally, we did not observe significant differences between
the total and polyadenylated forms of any transcript dur-
ing embryo development from zygote to hatched blasto-
cysts.
Regulatory elements in the 3' untranslated region
We searched the 3' untranslated region of the transcripts
for some of the regulatory sequences that are known to beBMC Developmental Biology 2007, 7:125 http://www.biomedcentral.com/1471-213X/7/125
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involved in the post-transcriptional regulation of mater-
nal RNA in model species. There is no unique consensus
sequence for the CPE, but rather variants from the basic
U4–5A1–2U sequence were identified in xenopus and
mouse within 100 nucleotides upstream the nuclear poly-
adenylation signal [5,9,35] Based on this definition,
potential CPE-like sequences were found in ID2,  ID3,
CCNB1, MELK, RNF18, STELLA and AURKA (Table 1).
Except for ID2, their total and polyadenylated forms were
not differentially regulated during in vitro or in vivo mat-
uration (Fig. 2, no *). Reciprocally, no such CPE could be
recognized within the 3' untranslated region of CDC2,
PRDX1, PRDX2, MATER, NALP9 and ZAR1 transcripts, or
much farther from the nuclear polyadenylation signal for
Variation of maternal transcripts during in vitro and in vivo maturation Figure 2
Variation of maternal transcripts during in vitro and in vivo maturation. Variation of transcripts total forms (dark 
color bars) or polyadenylated forms (light color bars) during in vitro (blue) or in vivo (red) oocyte maturation. The ratio to the 
mean value in immature oocytes is represented (mean ± SEM). IO and MO refer to immature oocytes and mature oocytes 
respectively. For each gene and form, different letters indicate a significant difference between IO and MO; an asterisk indicates 
a significant difference between variation of total and polyadenylated forms; "≠" indicates a significant difference between in 
vitro and in vivo maturation (P < 0.05).
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ACTB; their polyadenylated forms all displayed a signifi-
cant decline as compared to their total form during in vivo
maturation (Fig. 2, *), as well as in vitro maturation
although below significance threshold for NALP9  and
ACTB. CPE-like sequences were present in BCAR4 tran-
scripts, either close to the nuclear polyadenylation signal
for variant 2, or 600 nucleotides upstream for variant 1
(Table 1). BCAR4 variant 1 exibited a similar profile as
NALP9 during in vitro maturation. When both variants
were analysed together, neither the total nor the polyade-
nylated transcripts appeared much affected (Fig. 2). Of
note, STELLA and ACTB contained U10CU8 and U12, U15
and U11 sequences respectively. These might be embry-
onic CPE, i.e. elements that target transcripts for cytoplas-
mic polyadenylation after fertilization [6]. Yet no such
polyadenylation was evidenced by real-time PCR.
Profile of transcripts throughout embryo development Figure 3
Profile of transcripts throughout embryo development. Analysis of transcripts total forms (dark blue) and polyade-
nylated forms (light blue) during early embryo development: in vitro matured oocyte (MO), in vitro cultured zygote (Z), 2-, 4-, 
5/8-cell embryos, morula (M), expanded blastocysts (EB) and hatched blastocysts (HB). The ratio to immature oocytes (set at 1, 
dotted line) is shown (mean ± SEM). Within the profiles of the total form or polyadenylated form, different superscripts indi-
cate a significant difference (P < 0.05).
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We also searched the 3' untranslated region for so called
A/U rich element (ARE) that can target corresponding
transcripts for active deadenylation, as opposed to the
default deadenylation pathway (Table 1). Although there
is no strict consensus sequence, AREs have tentatively
been grouped into three major classes [36,37] Class I and
II ARE contain one or several dispersed or adjacent copies
of AUUUA motifs in a U-rich context; such motifs were
found in bovine ACTB, CDC2, ID2, ID3, MELK, RNF18,
STELLA and CCNB1 (Table 1). Class III ARE are described
as over 50 nucleotide long U-rich regions; several tran-
scripts may fall into this category. Finally, the presence of
multiple UGU motif in a U/G-rich context has also been
reported to target mRNA for deadenylation [38]; several
bovine transcripts indeed contained at least 4 copies of
the triplet within 45 nucleotides. But altogether, no obvi-
ous correlation appeared between the presence of putative
ARE motifs or UGU-rich sequences and the transcripts
profile during maturation or development.
Discussion
In this study, we have characterized four novel bovine
genes with a preferential oocyte expression. Then, using
real-time PCR, we have analysed these and other maternal
transcripts for changes in their abundance and polyade-
nylation during in vitro or in vivo maturation as well as in
vitro development up until the hatched blastocyst stage.
Influence of polyA tail onto transcripts detection by real 
time PCR and microarrays
A few studies have commented on the different apparent
transcript levels deduced from real time PCR onto cDNA
synthesized from oligo(dT) or random primers in bovine
oocytes and embryos [39-41] Here we extend this obser-
vation to a number of oocyte-specific or non specific tran-
scripts. The discrepancy is attributed to variations in the
polyA tail, which is of major interest in this model due to
the predominantly post-transcriptional regulation of gene
expression in FGO and pre-MET embryos. We may also
suspect a similar bias when polyadenylated RNA are puri-
fied [42-45] Indeed, the influence of polyA tail has conse-
quences beyond the analysis of real time PCR data, into
the field of embryogenomics. Due to limited biological
samples, amplified probes are usually generated from
mammalian oocytes/embryos for hybridizing onto micro-
array, through protocols that involve reverse transcription
from oligo(dT). Therefore, a similar bias associated with
the polyA tail is expected in these transcriptomic analyses.
Although this had been suggested before, experimental
validation analyzing both the total and polyadenylated
transcripts was lacking. In this study we have included six
genes previously identified by DNA array as markers of
oocyte maturation: CDC2, PRDX1 and PRDX2 transcripts
were shown to be negatively regulated, while CCNB1, ID2
and ID3 were positively regulated [33]. Here, using real
time PCR, we observed only a minor degradation of five
transcripts (all but ID2) during maturation. But we did
observe a dramatic decrease in polyadenylated transcripts
level for CDC2,  PRDX1  and  PRDX2, while ID3  and
CCNB1  polyadenylated transcripts appeared hardly
affected. These results indeed confirm that the array exper-
iment was influenced by the polyadenylation status of
these transcripts. Similarly, down regulation of MATER
during oocyte maturation, as observed on a microarray
[46], must reflect the significant decrease of the polyade-
nylated transcript evidenced here. In our experiment, ID2
did not follow the expected pattern: while among up-reg-
ulated transcripts revealed by DNA array screening, the
Table 1: putative regulatory elements and their position relative to the nuclear polyadenylation signal (NPS)
gene (transcript variant) CPE-like sequence (distance from NPS) Class I/II ARE-like motif (distance from NPS)
ACTB UUUUUAAU (340 nt) AUUUA (447 nt)
AURKA UUUUAAAU (5 nt) none
BCAR4 (v1) UUUUUAU (633 nt) none
BCAR4 (v1) UUUUAAU (686 nt)
BCAR4 (v2) UUUUAAU (12 nt) none
CCNB1 UUUUAAU (overlapping) AUUUAUUUA (5 nt)
CDC2 none AUUUA (57 nt)
ID2 UUUUUAU (35 nt) AUUUA (402 nt, 295 nt, 163 nt)
ID3 UUUUUAU (19 nt) AUUUA (85 nt)
MATER none none
MELK UUUUUAAU (17 nt) AUUUA (87 nt)
MELK UUUUUAAAU (106 nt)
NALP9 none none
PRDX1 none none
PRDX2 none none
RNF18 UUUUAU (3 nt) AUUUA (overlapping with CPE)
STELLA UUCUAAU (24 nt) AUUUA (536 nt)
ZAR1 none noneBMC Developmental Biology 2007, 7:125 http://www.biomedcentral.com/1471-213X/7/125
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polyadenylated transcript displayed a significant decline
when assessed by real time PCR. We have currently no sat-
isfying explanation for this discrepancy. Hybridization of
a non-specific probe due to cross-species hybridization
appears unlikely due to the high sequence conservation
(94%) between the bovine and human coding sequences.
Alternatively, a different transcript variant might have
hybridized onto the array than the one studied by real
time PCR.
Altogether, our results should prompt to reconsider inter-
pretation of DNA array and real-time PCR data in models
with potential regulation of the polyA tail. In mouse and
bovine oocytes and embryos, array validation experi-
ments were based on reverse-transcription initiated either
from oligo(dT) [44,45,47] or from a mix of both
oligo(dT) and random hexamers [48]. In order to mini-
mize the impact of variable polyA tails, a modified proto-
col for probe amplification was recently developed [49].
On the other hand, detecting transcripts polyadenylation
status on an array may be viewed as an asset, since it pro-
vides a footprint of mRNA that can be translated at a given
stage, circumventing the need for purifying polyade-
nylated transcripts [50].
Selective deadenylation of maternal transcripts during in 
vitro maturation
Maturation-associated degradation of stored maternal
transcripts has been known for a long time. In the mouse,
earlier studies reported a 19% decrease in RNA content, as
measured by ethidium bromide fluorescence; most of it
was accounted for by the degradation of rRNA [51,52]
Here, bovine 18S ribosomal RNA was found to decrease
during in vitro maturation by 22% (not statistically signif-
icant), a moderate degradation that could not be observed
previously by Northern blot [39]. Our value appears fairly
close to the value reported in the mouse. Yet, based on dif-
ferent developmental kinetics in both species, one might
have expected a lesser extent of degradation in the bovine,
as maternal rRNA will be required to sustain translation in
embryo for several days versus only a few hours in mouse.
A higher absolute RNA content in bovine oocytes as com-
pared to mouse oocytes [53] might compensate for this
similar global degradation rate.
Non ribosomal RNA is also affected, but the destruction
of transcripts during maturation in mice appears a selec-
tive rather than promiscuous process: this was observed
on individual genes in earlier studies [54] and was
recently confirmed using a microarray [49]. Here, most
transcripts displayed a limited degradation during matu-
ration. Within our set of genes, MATER, PRDX1 and ID2
transcripts were most affected, over 33% degraded. Degra-
dation of mouse Mater transcript in ovulated oocytes was
also recently reported [49]. Contrasted profiles were
observed for the polyadenylated forms. In this respect,
oocyte specific transcripts did not exhibit a uniform or a
particular pattern; a similar heterogeneity was observed
for housekeeping genes [40]. For a few genes, protein data
are available. During in vitro maturation, the level of
CDC2 and MATER proteins was not much altered as
observed by Western blot [55,56], while an isoform of
PRDX2 was shown to be synthesized through a proteom-
ics approach [57]. Here, all three polyadenylated tran-
scripts displayed a major decline. This apparent
discrepancy may only reflect complex post-transcriptional
and translational control, and illustrates the uncoupling
of transcriptome and proteome in FGO and mature
oocytes.
Comparison of in vitro and in vivo maturation
Whether considering variation of total or polyadenylated
transcripts, for most genes we did not evidence a different
pattern after in vitro vs in vivo maturation. Indeed, for
polyadenylated transcripts mean values were often
remarkably close. Overall, our data support the notion
that degradation and deadenylation are not severely
affected by in vitro maturation as compared to in vivo
maturation. Lower developmental competence of in vitro
matured oocytes should not be attributed to a general
alteration of post-transcriptional regulation of maternal
transcripts. Yet the following points have to be kept in
mind. First, we considered only relative variations
between immature and mature oocytes; should a tran-
script be more abundant at both stages in one model (in
vitro or in vivo maturation), the corresponding ratio
might not be affected. Second, we collected oocytes before
and after maturation, but not in the course of maturation,
when transient differences might have been revealed.
Third, it can not be excluded that superovulation treat-
ment affects oocyte transcriptome, so that OPU oocytes
may not reflect normal physiology.
An intriguing exception was PRDX1, whose total form
declined more severely during in vivo as compared to in
vitro maturation. This transcript was reported to increase
in oocytes from growing follicles over 8 mm in diameter
[58]; however, direct comparison with our own results is
difficult since in this paper, there is no mention of
whether transcript total form or only polyadenylated form
was quantified, and data were normalized to an internal
rather than an exogenous reference. In our study, imma-
ture oocytes were meant to be collected both in vivo and
post-mortem from follicles under 8 mm, and thus the fol-
licle size should not impact our data. Altogether, these
studies may indicate that PRDX1 level in oocytes is partic-
ularly sensitive to environmental changes during late fol-
liculogenesis and maturation. Analysis in other
physiological models will reveal whether it is a general
marker of bovine oocyte developmental competence.BMC Developmental Biology 2007, 7:125 http://www.biomedcentral.com/1471-213X/7/125
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In a previous study, a correlation between shorter polyA
tail and low developmental competence had been
reported; the difference in polyA tail could be observed
both before and after in vitro maturation [59]. The
authors considered a different model of oocyte quality,
based on the morphology of the ovary: their competent
oocytes, fairly similar to our post mortem collected
oocytes, were compared with oocytes with really poor
developmental (5% blastocyst rate) [60].
Profile of maternal transcripts during embryo development
Profiles during embryo development reflected the degra-
dation of maternal transcripts between the immature
oocyte and the 5/8-cell stage. In morulae and blastocysts,
detection of 18S and ACTB increased, reflecting embry-
onic genome activation. Strikingly, oocyte markers con-
tinued to decline in morulae, often below detection level.
Thus they were not activated at the time of major genome
activation, as previously reported for MATER,  OOSP1,
BMP15, GDF9, ZAR1 and NALP9 [22,24,27,56] and for
the vast majority of mouse oocyte specific genes [2]. All
but MELK remained silent in expanded and hatched blas-
tocysts. Interestingly, Melk is also activated in mouse 8-
cell embryos [2,19]
Most transcripts displayed a rapid decline during the ear-
lier stages of embryo production, i.e. oocyte maturation,
fertilization and zygote formation. BCAR4 was fairly con-
stant during maturation, and then dropped concomi-
tantly with zygote formation. Whether this decline
follows translation of a protein required for early embry-
ogenesis remains to be investigated. By contrast, MELK,
RNF18, STELLA variant 1 and AURKA exhibited a progres-
sive decrease from immature oocytes to 5/8-cell embryos.
Again, it is tempting to speculate that these transcripts
support translation at all stages to ensure continuous pro-
duction of a short half-lived protein necessary for devel-
opment; but they may just as likely be degraded without
supporting translation.
For all transcripts, the total and polyadenylated forms dis-
played parallel profiles throughout embryo development
from zygote to hatched blastocyst. We did not evidence
polyadenylation of a transcript at a specific stage when it
would be recruited for translation. However, this may be
too transient a phenomenon to be observed in a popula-
tion of several embryos. Rather, individual analysis of
numerous embryos might be required to reveal the few
embryos containing a transcript with an elongated polyA
tail.
CPE and the control of maternal transcripts during 
maturation
Globally, we observed a correlation between the presence
of a CPE-like sequence and the regulation of polyade-
nylated transcripts during maturation. The profiles of
transcripts without a CPE were coherent with them fol-
lowing the expected default deadenylation pathway.
Reciprocally, the polyadenylated forms of transcripts with
a putative CPE appeared stable, protected from further
deadenylation, with the exception of ID2. The divergent
profile of ID2 may indicate that a CPE is necessary, but
not sufficient for stabilizing the polyA tail. Alternatively, it
may have been generated by a distinct transcript variant
with a longer 3' untranslated region (and thus a far
upstream CPE, see BCAR4).
Altogether, our results are in agreement with conclusion
from a recent microarray study in Xenopus tropicalis: CPE
were under-represented in transcripts that were deade-
nylated during maturation, and over-represented in tran-
scripts that were polyadenylated during maturation or
substrate for post-fertilization deadenylation [61]. Here
we did not observe a significant increase that would result
from cytoplasmic polyadenylation. This is not unexpected
as the polyadenylated form may be transient and no
longer present in mature oocytes; a time-course analysis
might be necessary, especially during the first 6 to 10
hours when cytoplasmic polyadenylation is believed to
initiate [62,63] Alternatively, the elongation of the polyA
tail may not be sufficient to be detected by this methodol-
ogy; in fact, in a previous study polyadenylation of one
CCNB1 variant was observed using a PCR based polyA
test, but not by real-time PCR [64].
Conclusion
In this study, we have analyzed the regulation of selected
maternal transcripts during bovine oocyte maturation,
and its correlation with the presence of a putative CPE. As
a model of differential developmental competence, we
have compared maturation in vitro and maturation in
vivo. The control of degradation and deadenylation did
not appear globally compromised by in vitro manipula-
tion, as only PRDX1 exhibited strikingly different patterns
in the two conditions.
Methods
Post mortem oocyte collection and embryo production
Ovaries from adult cows were collected at a slaughter-
house and the oocyte-cumulus complexes were aspirated
from 3–8 mm follicles, selected based on morphological
criteria and washed in saline solution (for details see
[65]). Denuded germinal vesicle stage immature oocytes
and in vitro matured metaphase II oocytes (polar body
extrusion was verified) were obtained as previously
described [33]. Briefly, oocyte-cumulus complexes were
denuded by mechanical treatment either before or after in
vitro maturation in TCM199 (Sigma, Saint Quentin Falla-
vier, France) supplemented with 10 ng/ml epidermal
growth factor and 10% fetal calf serum for 22 h at 39°C inBMC Developmental Biology 2007, 7:125 http://www.biomedcentral.com/1471-213X/7/125
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water-saturated air with 5% carbon dioxide. Embryos
were produced as previously described [56]. Groups of 10
embryos were collected over preimplantation develop-
ment: zygotes and 2-cell embryos (day 2), 4-cell, 5 to 8-
cell embryos (day 3), morulae (day 5), expanded blasto-
cysts (day 7) and hatched blastocysts (day 8). All oocyte
and embryo samples were stored frozen in RNA later
(Ambion, UK).
In vivo oocyte collection
All procedures were approved by the Agricultural and Sci-
entific Research Government Committees in accordance
with the guidelines for Care and Use of Agricultural Ani-
mals in Agricultural Research and Teaching (approval
PB380). Oocytes were collected in vivo from eight super-
ovulated Montbeliard cows by OPU at 12 or 60 h after
prostaglandin injection to collect immature and in vivo-
matured oocytes, respectively. Oocytes were denuded as
described above, and stored frozen in RNAlater.
Characterization of full-length cDNA
Gonads were collected from animals slaughtered in a
commercial abattoir. Other organs were collected from an
animal bred and killed in an experimental setting; all pro-
cedures were approved by the Agricultural and Scientific
Research Government Committees in accordance with the
guidelines for Care and Use of Agricultural Animals in
Agricultural Research and Teaching (approval A37801).
RNA was isolated from biopsies using Trizol (Invitrogen,
Cergy Pontoise, France) and DNAse-treated. RACE-PCR
and virtual Northern blot (i.e. Southern blot of full length
cDNA) were carried out as previously described [22].
Sequences are available from Genbank and from the Ovo-
genae programme database [66]. Primers sequences are
given in Table 2.
Reverse-transcription for real-time PCR
After adding 1 pg of luciferase mRNA (Promega, Charbon-
nières-les-bains, France) per oocyte/embryo as an exoge-
nous standard, total DNAse-treated RNA was purified
from 4 independent pools of 10 oocytes or embryos at
each stage (or 5 to 16 OPU oocytes) using the Picopure
RNA isolation kit (Alphelys, Plaisir, France). Reverse tran-
scription was performed at 37°C for 50 min using
oligo(dT)15  primers (Promega) or random hexamers
(Promega) by mouse Moloney leukaemia virus reverse
transcriptase (Invitrogen) onto RNA equivalent to 2.5 in
vivo collected oocytes and 5 post-mortem collected
oocytes or in vitro produced embryos.
Real time PCR
Target cDNA were quantified by real-time PCR using iQ
SYBR green supermix (Bio-Rad, Marnes la Coquette,
France) with a iCycler or MyiQCycler system (Bio-Rad)
using specific primers (sequences are presented in table
2). Primers for CCNB1  did not discriminate variants
present in bovine oocytes[64]. A 3-step protocol (95°C
for 30 sec, 60°C for 30 sec, 72°C for 20 sec) was repeated
for 40 to 50 cycles, followed by acquisition of the melting
curve. Amplicons were sequenced after cloning into pCRII
vector using TA cloning kit (Invitrogen). The standard
curve was deduced from serial dilutions of a plasmid
including the target sequence, adjusted so that samples
would fall within the considered range. Depending on the
target gene, a cDNA amount equivalent to 0.0005 to 0.2
oocyte or embryo was used in triplicate PCR reactions,
and the median value was considered (0 when not
detected). For each sample, the data were normalized to
the median value for exogenous luciferase. The gene/luci-
ferase value in mature oocytes was then compared to this
same ratio in immature oocytes (mean of four oocyte or
embryo collections); data are presented as mean ± SEM.
For each gene, Mann-Whitney comparison test was used
to compare a) detection in mature vs immature oocytes,
b) data obtained with random hexamers primed vs
oligo(dT)15 primed RT products, c) regulation in in vitro
matured vs in vivo matured oocytes. For embryonic devel-
opment from mature oocytes onwards, after analysis of
variance, differences were evaluated using Tukey compar-
ison test. In all instances, differences were considered sta-
tistically significant at the 95% confidence level (P <
0.05).
Authors' contributions
All authors were involved in biological material collec-
tion. AT participated in experimental design, data analy-
sis, figure editing and carried out most experimental work:
oocyte in vitro maturation, embryo production, RNA
extraction, real-time PCR for oocyte marker genes, statisti-
cal analysis and characterization of oocyte markers MELK
and RNF18. PP carried out real-time PCR experiments
onto genes previously identified as oocyte maturation
markers. CP carried out in vitro maturation and embryo
production. SP characterized STELLA and BCAR4. SU and
JMT supervised and participated in the study of AURKA.
PH and CJ supervised and carried out animal ovarian
stimulation and OPU. RDT designed and supervised the
study, analysed data and wrote the manuscript. All
authors have read and approved the final manuscript.BMC Developmental Biology 2007, 7:125 http://www.biomedcentral.com/1471-213X/7/125
Page 11 of 13
(page number not for citation purposes)
Acknowledgements
AT is supported by fellowships from the Conseil Régional Région Centre 
and Institut National de la Recherche Agronomique. This work is part of 
the "Ovogenae" program, a Genanimal project sponsored by grants from 
the french Ministry of Research (#03P409) and Apis-Gene. The authors 
thank Gael Ramé for collecting ovaries at the slaughterhouse, Sylviane Pon-
chon, Cyril Gonzalez and staff of UNCEIA-UCEAR Chateauvillain for OPU 
oocyte collection and animal care, and Patrice Dehais of the sigenae team 
for SSH library sequences analysis.
References
1. Sharov AA, Piao Y, Matoba R, Dudekula DB, Qian Y, VanBuren V,
Falco G, Martin PR, Stagg CA, Bassey UC, Wang Y, Carter MG,
Hamatani T, Aiba K, Akutsu H, Sharova L, Tanaka TS, Kimber WL,
Yoshikawa T, Jaradat SA, Pantano S, Nagaraja R, Boheler KR, Taub D,
Hodes RJ, Longo DL, Schlessinger D, Keller J, Klotz E, Kelsoe G,
Table 2: primers sequences
gene (transcript variant) primer sequence Genbank accession
luciferase fwd TCATTCTTCGCCAAAAGCACTCTG
rev AGCCCATATCCTTGTCGTATCCC
18S fwd CGGACCAGAGCGAAAGCATTTG DQ222453
rev GAATAACGCCGCCGCATCG
ACTB fwd1 CGTGACATTAAGGAGAAGCTGTGC NM_173979
fwd2 GCGTGACATCAAGGAGAAGC
rev1 CTCAGGAGGAGCAATGATCTTGAT
rev2 TGGAAGGTGGACAGGGAGGC
MATER fwd GCTGGAGGCGTGTGGACTG NM_001007814
rev GGTCTGTAGATTAGAGGTGGGATGC
NALP9 fwd GCGGCGGTGCTGTGTGAAG NM_001024664
rev CTGCGTCTGCCCTCGTCATC
ZAR1 fwd TGCCGAACATGCCAGAAG NM_001076203
rev TCACAGGATAGGCGTTTGC
MELK fwd1 CCTTGATGAAGATTGTGTAACGGAAC EF446902
fwd2 CCAGGTAGCAAAAGGAAAGGC
rev1 GGAAGAAAGAAGCCTTAAACGAACC
rev2 CTTTGGAAGAACAGAGCATTATTTC
BCAR4 (v1+v2) fwd1 GAAGGGTGTTTGCTGATTTCTGTTAAG EF446907
fwd2 CCTGAAGGGTGTTTGCTGAT
rev1 CATTGTTGTTACCAGGGCGAAGG
rev2 CCAGGTCCACTGACTGTTAGC
BCAR4 (v1) fwd TCTTGTCCATCGTCCTGTCCTG EF446906
rev GTAGACCACACCATTACATCAGAGG
RNF18 fwd1 TGCTGTGCTTGTTCTGCTCTC EF446903
fwd2 GCTTCTTTTGCTCTCTCTCATCTCCTC
rev1 GCTCGTATCATCACCAGTCGTAG
rev2 AATGGTGGCAGGGTCTGTGAA
STELLA (v1) fwd TAGGACTACGCCCATTCACC EF446904
rev1 TGCTGTAGGCTCAAACTGCTC
rev2 GGGTCCAGGTTGGGTTATCT
STELLA (v2) fwd1 GCGGGGATGGCTACTCTTC EF446905
fwd2 TCTTCATCCCCTACAAAAGCA
rev1 TGCTGTAGGCTCAAACTGCTC
rev2 GGGTCCAGGTTGGGTTATCT
CCNB1 fwd TGGGTCGGCCTCTACCTTTGCACTTC NM_001045872
rev CGATGTGGCATACTTGTTCTTGATAGTCA
CDC2 fwd ATGGCTTGGATCTGCTCTCG NM_174016
rev CATTAAAGTACGGATGATTCAGTGC
PRDX1 fwd TCAAGCCTGATGTCCAGAAGAGC NM_174431
rev CCGTCCTGTCCCACACCAC
PRDX2 fwd GATTATGGCGTGCTGAAGGAAGATG NM_174763
rev GAGCGTCCCACAGGCAAGTC
ID2 fwd CAGTCCAGTGAGGTCCGTTAGG AW464352
rev GCAGGCTCATCGGGTCGTC
ID3 fwd TGACGACATGAACCACTGCTACTC BM106920
rev GCTGTCTGGATGGGAAGATGCG
AURKA fwd TCGGGAGGACTTGGTTTCTT DQ334808
rev TGTGCTTGTGAAGGAACACGBMC Developmental Biology 2007, 7:125 http://www.biomedcentral.com/1471-213X/7/125
Page 12 of 13
(page number not for citation purposes)
Umezawa A, Vescovi AL, Rossant J, Kunath T, Hogan BL, Curci A,
D'Urso M, Kelso J, Hide W, Ko MS: Transcriptome analysis of
mouse stem cells and early embryos.  PLoS Biol 2003, 1:E74.
2. Hamatani T, Carter MG, Sharov AA, Ko MS: Dynamics of global
gene expression changes during mouse preimplantation
development.  Dev Cell 2004, 6:117-131.
3. Kocabas AM, Crosby J, Ross PJ, Otu HH, Beyhan Z, Can H, Tam WL,
Rosa GJ, Halgren RG, Lim B, Fernandez E, Cibelli JB: The transcrip-
tome of human oocytes.  P r o c  N a t l  A c a d  S c i  U S A  2006,
103:14027-14032.
4. Misirlioglu M, Page GP, Sagirkaya H, Kaya A, Parrish JJ, First NL,
Memili E: Dynamics of global transcriptome in bovine
matured oocytes and preimplantation embryos.  Proc Natl
Acad Sci USA 2006, 103:18905-18910.
5. Mendez R, Richter JD: Translational control by CPEB: a means
to the end.  Nat Rev Mol Cell Biol 2001, 2:521-529.
6. Richter JD: Cytoplasmic polyadenylation in development and
beyond.  Microbiol Mol Biol Rev 1999, 63:446-456.
7. Racki WJ, Richter JD: CPEB controls oocyte growth and follicle
development in the mouse.  Development 2006, 133:4527-4537.
8. Varnum SM, Wormington WM: Deadenylation of maternal
mRNAs during Xenopus oocyte maturation does not
require specific cis-sequences: a default mechanism for
translational control.  Genes Dev 1990, 4:2278-2286.
9. Paynton BV, Bachvarova R: Polyadenylation and deadenylation
of maternal mRNAs during oocyte growth and maturation
in the mouse.  Mol Reprod Dev 1994, 37:172-180.
10. Evsikov AV, Graber JH, Brockman JM, Hampl A, Holbrook AE, Singh
P, Eppig JJ, Solter D, Knowles BB: Cracking the egg: molecular
dynamics and evolutionary aspects of the transition from the
fully grown oocyte to embryo.  Genes Dev 2006, 20:2713-2127.
11. Dean J: Oocyte-specific genes regulate follicle formation, fer-
tility and early mouse development.  J Reprod Immunol 2002,
53:171-180.
12. Rajkovic A, Matzuk MM: Functional analysis of oocyte-
expressed genes using transgenic models.  Mol Cell Endocrinol
2002, 187:5-9.
13. Dade S, Callebaut I, Paillisson A, Bontoux M, Dalbies-Tran R, Monget
P: In silico identification and structural features of six new
genes similar to MATER specifically expressed in the oocyte.
Biochem Biophys Res Commun 2004, 324:547-553.
14. Tong ZB, Gold L, Pfeifer KE, Dorward H, Lee E, Bondy CA, Dean J,
Nelson LM: Mater, a maternal effect gene required for early
embryonic development in mice.  Nat Genet 2000, 26:267-268.
15. Wu X, Viveiros MM, Eppig JJ, Bai Y, Fitzpatrick SL, Matzuk MM:
Zygote arrest 1 (Zar1) is a novel maternal-effect gene criti-
cal for the oocyte-to-embryo transition.  Nat Genet 2003,
33:187-191.
16. Bortvin A, Goodheart M, Liao M, Page DC: Dppa3/Pgc7/stella is a
maternal factor and is not required for germ cell specifica-
tion in mice.  BMC Dev Biol 2004, 4:2.
17. Payer B, Saitou M, Barton SC, Thresher R, Dixon JP, Zahn D, Colledge
WH, Carlton MB, Nakano T, Surani MA: Stella is a maternal
effect gene required for normal early development in mice.
Curr Biol 2003, 13:2110-2117.
18. Yan C, Pendola FL, Jacob R, Lau AL, Eppig JJ, Matzuk MM: Oosp1
encodes a novel mouse oocyte-secreted protein.  Genesis
2001, 31:105-110.
19. Heyer BS, Warsowe J, Solter D, Knowles BB, Ackerman SL: New
member of the Snf1/AMPK kinase family, Melk, is expressed
in the mouse egg and preimplantation embryo.  Mol Reprod
Dev 1997, 47:148-156.
20. Dade S, Callebaut I, Mermillod P, Monget P: Identification of a new
expanding family of genes characterized by atypical LRR
domains. Localization of a cluster preferentially expressed in
oocyte.  FEBS Lett 2003, 555:533-538.
21. Minami N, Aizawa A, Ihara R, Miyamoto M, Ohashi A, Imai H: Oog-
enesin is a novel mouse protein expressed in oocytes and
early cleavage-stage embryos.  Biol Reprod 2003, 69:1736-1742.
22. Pennetier S, Uzbekova S, Perreau C, Papillier P, Mermillod P, Dalbies-
Tran R: Spatio-temporal expression of the germ cell marker
genes MATER, ZAR1, GDF9, BMP15, andVASA in adult
bovine tissues, oocytes, and preimplantation embryos.  Biol
Reprod 2004, 71:1359-1366.
23. Pennetier S, Uzbekova S, Guyader-Joly C, Humblot P, Mermillod P,
Dalbies-Tran R: Genes preferentially expressed in bovine
oocytes revealed by subtractive and suppressive hybridiza-
tion.  Biol Reprod 2005, 73:713-720.
24. Dalbies-Tran R, Papillier P, Pennetier S, Uzbekova S, Monget P:
Bovine mater-like NALP9 is an oocyte marker gene.  Mol
Reprod Dev 2005, 71:414-421.
25. Uzbekova S, Roy-Sabau M, Dalbies-Tran R, Perreau C, Papillier P,
Mompart F, Thelie A, Pennetier S, Cognie J, Cadoret V, Royere D,
Monget P, Mermillod P: Zygote arrest 1 gene in pig, cattle and
human: evidence of different transcript variants in male and
female germ cells.  Reprod Biol Endocrinol 2006, 4:12.
26. Vallee M, Robert C, Methot S, Palin MF, Sirard MA: Cross-species
hybridizations on a multi-species cDNA microarray to iden-
tify evolutionarily conserved genes expressed in oocytes.
BMC Genomics 2006, 7:113.
27. Tremblay K, Vigneault C, McGraw S, Morin G, Sirard MA: Identifi-
cation and characterization of a novel bovine oocyte-specific
secreted protein gene.  Gene 2006, 375:44-53.
28. Sirard MA, Richard F, Blondin P, Robert C: Contribution of the
oocyte to embryo quality.  Theriogenology 2006, 65:126-136.
29. Humblot P, Holm P, Lonergan P, Wrenzycki C, Lequarre AS, Joly CG,
Herrmann D, Lopes A, Rizos D, Niemann H, Callesen H: Effect of
stage of follicular growth during superovulation on develop-
mental competence of bovine oocytes.  Theriogenology 2005,
63:1149-1166.
30. Rizos D, Ward F, Duffy P, Boland MP, Lonergan P: Consequences
of bovine oocyte maturation, fertilization or early embryo
development in vitro versus in vivo: implications for blasto-
cyst yield and blastocyst quality.  Mol Reprod Dev 2002,
61:234-248.
31. Dieleman SJ, Hendriksen PJ, Viuff D, Thomsen PD, Hyttel P, Knijn HM,
Wrenzycki C, Kruip TA, Niemann H, Gadella BM, Bevers MM, Vos PL:
Effects of in vivo prematuration and in vivo final maturation
on developmental capacity and quality of pre-implantation
embryos.  Theriogenology 2002, 57:5-20.
32. van de Leemput EE, Vos PL, Zeinstra EC, Bevers MM, van der Wei-
jden GC, Dieleman SJ: Improved in vitro embryo development
using in vivo matured oocytes from heifers superovulated
with a controlled preovulatory LH surge.  Theriogenology 1999,
52:335-349.
33. Dalbies-Tran R, Mermillod P: Use of heterologous complemen-
tary DNA array screening to analyze bovine oocyte tran-
scriptome and its evolution during in vitro maturation.  Biol
Reprod 2003, 68:252-261.
34. Yoshikawa T, Seki N, Azuma T, Masuho Y, Muramatsu M, Miyajima N,
Saito T: Isolation of a cDNA for a novel human RING finger
protein gene, RNF18, by the virtual transcribed sequence
(VTS) approach(1).  Biochim Biophys Acta 2000, 1493:349-355.
35. Seydoux G: Mechanisms of translational control in early
development.  Curr Opin Genet Dev 1996, 6:555-561.
36. Chen CY, Shyu AB: AU-rich elements: characterization and
importance in mRNA degradation.  Trends Biochem Sci 1995,
20:465-470.
37. Barreau C, Paillard L, Osborne HB: AU-rich elements and associ-
ated factors: are there unifying principles?  Nucleic Acids Res
2005, 33:7138-7150.
38. Marquis J, Paillard L, Audic Y, Cosson B, Danos O, Le Bec C, Osborne
HB: CUG-BP1/CELF1 requires UGU-rich sequences for high-
affinity binding.  Biochem J 2006, 400:291-301.
39. Lequarre AS, Traverso JM, Marchandise J, Donnay I: Poly(A) RNA
is reduced by half during bovine oocyte maturation but
increases when meiotic arrest is maintained with CDK inhib-
itors.  Biol Reprod 2004, 71:425-431.
40. Bettegowda A, Patel OV, Ireland JJ, Smith GW: Quantitative anal-
ysis of messenger RNA abundance for ribosomal protein L-
15, cyclophilin-A, phosphoglycerokinase, beta-glucuroni-
dase, glyceraldehyde 3-phosphate dehydrogenase, beta-
actin, and histone H2A during bovine oocyte maturation and
early embryogenesis in vitro.  Mol Reprod Dev 2006, 73:267-278.
41. Vigneault C, Gilbert I, Sirard MA, Robert C: Using the histone H2a
transcript as an endogenous standard to study relative tran-
script abundance during bovine early development.  Mol
Reprod Dev 2006, 74:703-715.
42. Fair T, Murphy M, Rizos D, Moss C, Martin F, Boland MP, Lonergan P:
Analysis of differential maternal mRNA expression in devel-
opmentally competent and incompetent bovine two-cell
embryos.  Mol Reprod Dev 2004, 67:136-144.Publish with BioMed Central    and   every 
scientist can read your work free of charge
"BioMed Central will be the most significant development for 
disseminating the results of biomedical research in our lifetime."
Sir Paul Nurse, Cancer Research UK
Your research papers will be:
available free of charge to the entire biomedical community
peer reviewed and published  immediately upon acceptance
cited in PubMed and archived on PubMed Central 
yours — you keep the copyright
Submit your manuscript here:
http://www.biomedcentral.com/info/publishing_adv.asp
BioMedcentral
BMC Developmental Biology 2007, 7:125 http://www.biomedcentral.com/1471-213X/7/125
Page 13 of 13
(page number not for citation purposes)
43. Gutierrez-Adan A, Rizos D, Fair T, Moreira PN, Pintado B, de la
Fuente J, Boland MP, Lonergan P: Effect of speed of development
on mRNA expression pattern in early bovine embryos cul-
tured in vivo or in vitro.  Mol Reprod Dev 2004, 68:441-448.
44. Li XY, Cui XS, Kim NH: Transcription profile during maternal
to zygotic transition in the mouse embryo.  Reprod Fertil Dev
2006, 18:635-645.
45. Mamo S, Bodo S, Kobolak J, Polgar Z, Tolgyesi G, Dinnyes A: Gene
expression profiles of vitrified in vivo derived 8-cell stage
mouse embryos detected by high density oligonucleotide
microarrays.  Mol Reprod Dev 2006, 73:1380-1392.
46. Fair T, Carter F, Park S, Evans AC, Lonergan P: Global gene expres-
sion analysis during bovine oocyte in vitro maturation.  Theri-
ogenology 2007, 68(Suppl 1):S91-7.
47. Corcoran D, Fair T, Park S, Rizos D, Patel OV, Smith GW, Coussens
PM, Ireland JJ, Boland MP, Evans AC, Lonergan P: Suppressed
expression of genes involved in transcription and translation
in in vitro compared with in vivo cultured bovine embryos.
Reproduction 2006, 131:651-660.
48. Sagirkaya H, Misirlioglu M, Kaya A, First NL, Parrish JJ, Memili E:
Developmental and molecular correlates of bovine preim-
plantation embryos.  Reproduction 2006, 131:895-904.
49. Su YQ, Sugiura K, Woo Y, Wigglesworth K, Kamdar S, Affourtit J,
Eppig JJ: Selective degradation of transcripts during meiotic
maturation of mouse oocytes.  Dev Biol 2007, 302:104-117.
50. Sakurai T, Sato M, Kimura M: Diverse patterns of poly(A) tail
elongation and shortening of murine maternal mRNAs from
fully grown oocyte to 2-cell embryo stages.  Biochem Biophys Res
Commun 2005, 336:1181-1189.
51. Bachvarova R, De Leon V, Johnson A, Kaplan G, Paynton BV:
Changes in total RNA, polyadenylated RNA, and actin
mRNA during meiotic maturation of mouse oocytes.  Dev Biol
1985, 108:325-331.
52. Paynton BV, Rempel R, Bachvarova R: Changes in state of ade-
nylation and time course of degradation of maternal mRNAs
during oocyte maturation and early embryonic development
in the mouse.  Dev Biol 1988, 129:304-314.
53. Olszanska B, Borgul A: Maternal RNA content in oocytes of sev-
eral mammalian and avian species.  J Exp Zool 1993,
265:317-320.
54. Bachvarova R, Paynton BV: Gene expression during growth and
meiotic maturation of mouse oocytes.  Prog Clin Biol Res 1988,
267:67-85.
55. Vigneron C, Perreau C, Dalbies-Tran R, Joly C, Humblot P, Uzbekova
S, Mermillod P: Protein synthesis and mRNA storage in cattle
oocytes maintained under meiotic block by roscovitine inhi-
bition of MPF activity.  Mol Reprod Dev 2004, 69:457-465.
56. Pennetier S, Perreau C, Uzbekova S, Thelie A, Delaleu B, Mermillod
P, Dalbies-Tran R: MATER protein expression and intracellular
localization throughout folliculogenesis and preimplantation
embryo development in the bovine.  BMC Dev Biol 2006, 6:26.
57. Bhojwani M, Rudolph E, Kanitz W, Zuehlke H, Schneider F, Tomek
W: Molecular analysis of maturation processes by protein
and phosphoprotein profiling during in vitro maturation of
bovine oocytes: a proteomic approach.  Cloning Stem Cells 2006,
8:259-274.
58. Mourot M, Dufort I, Gravel C, Algriany O, Dieleman S, Sirard MA:
The influence of follicle size, FSH-enriched maturation
medium, and early cleavage on bovine oocyte maternal
mRNA levels.  Mol Reprod Dev 2006, 73:1367-1379.
59. Brevini-Gandolfi TA, Favetta LA, Mauri L, Luciano AM, Cillo F, Gan-
dolfi F: Changes in poly(A) tail length of maternal transcripts
during in vitro maturation of bovine oocytes and their rela-
tion with developmental competence.  Mol Reprod Dev 1999,
52:427-433.
60. Gandolfi F, Luciano AM, Modina S, Ponzini A, Pocar P, Armstrong DT,
Lauria A: The in vitro developmental competence of bovine
oocytes can be related to the morphology of the ovary.  The-
riogenology 1997, 48:1153-1160.
61. Graindorge A, Thuret R, Pollet N, Osborne HB, Audic Y: Identifica-
tion of post-transcriptionally regulated Xenopus tropicalis
maternal mRNAs by microarray.  Nucleic Acids Res 2006,
34:986-995.
62. Krischek C, Meinecke B: In vitro maturation of bovine oocytes
requires polyadenylation of mRNAs coding proteins for
chromatin condensation, spindle assembly, MPF and MAP
kinase activation.  Anim Reprod Sci 2002, 73:129-140.
63. Traverso JM, Donnay I, Lequarre AS: Effects of polyadenylation
inhibition on meiosis progression in relation to the polyade-
nylation status of cyclins A2 and B1 during in vitro matura-
tion of bovine oocytes.  Mol Reprod Dev 2005, 71:107-114.
64. Tremblay K, Vigneault C, McGraw S, Sirard MA: Expression of cyc-
lin B1 messenger RNA isoforms and initiation of cytoplasmic
polyadenylation in the bovine oocyte.  Biol Reprod 2005,
72:1037-1044.
65. Mermillod P, Tomanek M, Marchal R, Meijer L: High developmen-
tal competence of cattle oocytes maintained at the germinal
vesicle stage for 24 hours in culture by specific inhibition of
MPF kinase activity.  Mol Reprod Dev 2000, 55:89-95.
66. Ovogenae database   [http://wcentre.tours.inra.fr/ovogenae]